title: Imaging appearance of treated hepatocellular carcinoma.
abstract: Surgical resection and imaging guided treatments play a crucial role in the management of hepatocellular carcinoma (HCC). Although the primary end point of treatment of HCC is survival, radiological response could be a surrogate end point of survival, and has a key role in HCC decision-making process. However, radiological assessment of HCC treatment efficacy is often controversial. There are few doubts on the evaluation of surgical resection; in fact, all known tumor sites should be removed. However, an unenhancing partial linear peripheral halo, in most cases, surrounding a fluid collection reducing in size during follow-up is demonstrated in successfully resected tumor with bipolar radiofrequency electrosurgical device. Efficacy assessment of locoregional therapies is more controversial and differs between percutaneous ablation (e.g., radiofrequency ablation and percutaneous ethanol injection) and transarterial treatments (e.g., conventional transarterial chemoembolization, transarterial chemoembolization with drug eluting beads and radioembolization). Finally, a different approach should be used for new systemic agent that, though not reducing tumor mass, could have a benefit on survival by delaying tumor progression and death. The purpose of this brief article is to review HCC imaging appearance after treatment.
authors.affiliation: Francesco Agnello, Giuseppe Salvaggio, Roberto Lagalla, Massimo Midiri, Giuseppe Brancatelli, Section of Radiological Sciences, DIBIMEF, University of Palermo, 90127 Palermo, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Agnello
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Salvaggio
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cabibbo
authors.forename: Marcello
authors.initials: M
authors.lastname: Maida
authors.forename: Roberto
authors.initials: R
authors.lastname: Lagalla
authors.forename: Massimo
authors.initials: M
authors.lastname: Midiri
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Brancatelli
keywords: Hepatocellular carcinoma; Imaging; Treatment
references.citation: Hepatology. 2009 Feb;49(2):453-9
references.pmid: 19065676
references.citation: AJR Am J Roentgenol. 2009 Oct;193(4):1044-52
references.pmid: 19770328
references.citation: Radiology. 2002 Dec;225(3):773-80
references.pmid: 12461260
references.citation: Semin Intervent Radiol. 2006 Jun;23(2):119-25
references.pmid: 21326755
references.citation: Radiology. 2008 Jun;247(3):896-902
references.pmid: 18487541
references.citation: Eur J Radiol. 2012 Apr;81(4):663-70
references.pmid: 21306849
references.citation: J Hepatol. 2013 Jan;58(1):169-77
references.pmid: 22944253
references.citation: AJR Am J Roentgenol. 1994 Apr;162(4):827-31
references.pmid: 8141000
references.citation: Radiographics. 2012 Jul-Aug;32(4):1121-32
references.pmid: 22786998
references.citation: Cardiovasc Intervent Radiol. 2010 Jun;33(3):532-40
references.pmid: 19847482
references.citation: Hepatogastroenterology. 2013 Sep;60(126):1399-404
references.pmid: 23635508
references.citation: N Engl J Med. 2008 Jul 24;359(4):378-90
references.pmid: 18650514
references.citation: Aliment Pharmacol Ther. 2011 Jul;34(2):196-204
references.pmid: 21564144
references.citation: AJR Am J Roentgenol. 2008 Jul;191(1):215-20
references.pmid: 18562748
references.citation: AJR Am J Roentgenol. 2008 Jul;191(1):133-9
references.pmid: 18562736
references.citation: Hepatology. 2011 Dec;54(6):2055-63
references.pmid: 21898496
references.citation: Radiology. 2002 Apr;223(1):255-62
references.pmid: 11930075
references.citation: J Vasc Interv Radiol. 2009 Jan;20(1):30-8
references.pmid: 19028117
references.citation: Am J Gastroenterol. 2009 Feb;104(2):514-24
references.pmid: 19174803
references.citation: AJR Am J Roentgenol. 2013 Jan;200(1):184-93
references.pmid: 23255761
references.citation: Dig Liver Dis. 2013 Sep;45(9):776-81
references.pmid: 23578581
references.citation: AJR Am J Roentgenol. 2005 Jul;185(1):225-31
references.pmid: 15972428
references.citation: AJR Am J Roentgenol. 2013 Jan;200(1):194-204
references.pmid: 23255762
references.citation: Radiographics. 2008 Jan-Feb;28(1):81-99
references.pmid: 18203932
references.citation: Oncologist. 2010;15 Suppl 4:1-4
references.pmid: 21115575
references.citation: HPB Surg. 2010;2010:403097
references.pmid: 20862384
references.citation: Semin Liver Dis. 2010 Feb;30(1):52-60
references.pmid: 20175033
references.citation: Expert Rev Anticancer Ther. 2013 Apr;13(4):469-79
references.pmid: 23560841
references.citation: AJR Am J Roentgenol. 2013 Jul;201(1):80-96
references.pmid: 23789661
references.citation: Radiology. 2012 Jan;262(1):43-58
references.pmid: 22190656
references.citation: J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S425-34
references.pmid: 19560030
references.citation: AJR Am J Roentgenol. 2012 Aug;199(2):349-59
references.pmid: 22826396
references.citation: Hepatology. 2011 Mar;53(3):1020-2
references.pmid: 21374666
references.citation: Future Oncol. 2013 Jun;9(6):845-54
references.pmid: 23718305
references.citation: Clin Radiol. 2012 Jul;67(7):649-55
references.pmid: 22300821
references.citation: Radiology. 2005 Mar;234(3):954-60
references.pmid: 15681691
references.citation: Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52
references.pmid: 19908093
references.citation: J Surg Oncol. 2008 Nov 1;98(6):407-10
references.pmid: 18683211